长非编码RNA在IgA病中的作用:综合性综述
Xiaoxuan Huang1, Lan Chen1, Jinxuan He1
1Department of Nephrology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Renal failure
|May 7, 2025
概括
长非编码RNAs (lncRNAs) 越来越多地涉及免疫球蛋白A脏病 (IgAN) 的发病. 本综述巩固了IgAN中的IncRNA研究,强调了它们作为这种常见病的生物标志物的作用和潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是全球最常见的原发性血球炎,通常导致末期脏病 (ESKD).
- 驱动IGAN进展的确切机制尚未完全理解.
- 长非编码RNAs (lncRNAs) 是基因表达的关键调节者,在包括IgAN在内的各种疾病中观察到的改变模式.
研究的目的:
- 审查当前关于lncRNAs在IgAN病变发生中的作用的文献.
- 为了整合有关IgAN涉及的特定lncRNAs的发现.
- 确定潜在的未来研究方向和与IgAN. lncRNAs相关的治疗目标.
主要方法:
- 对Igan患者数据的生物信息分析.
- 对差异表达的 lncRNAs 的鉴定.
- 相关性研究将lncRNA表达与临床标志物和疾病严重程度联系起来.
- 实验验证IncRNA参与IgAN病原的实验验证.
主要成果:
- 几种lncRNAs (例如HOTAIR,H19,MALAT1,MIR31HG,Lnc-TSI,Inc-CHAF1B-3,ICR,PTTG3P,CRNDE) 显示出对Igan的差异表达或遗传联系.
- 特定的lncRNA与IgAN敏感性,临床特征,纤维化和疾病进展有关.
- 血清H19可能起到保护因素的作用,而其他如ICR与Igan严重程度相关.
结论:
- lncRNAs在IgAN的发病和进展中起着重要的作用.
- 某些 lncRNAs 显示为IgAN诊断,预后和治疗点的生物标志物的潜力.
- 进一步的研究对于阐明 lncRNA 功能和开发有效的基于 lncRNA 的 IgAN 疗法至关重要.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
03:18Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K